Cancer52 has announced its new three-year strategy, which focuses on the following three key goals voice, influence and sustainability.

We're pleased to welcome Lynch Syndrome UK as the latest charity to join Cancer52.

EGFR Positive UK joins Cancer52 as our newest member.

In this State of Nation Report: No Cancer Too Rare, Cancer52 reviews policy developments since the 2024 General Election that will shape the next 10 years of cancer services. The report also reflects on what these developments means for our priorities for the UK Government and for making rare and less common cancers a priority in national policy.

Cancer52’s newest member, The Bardo Foundation is an international childhood cancer charity founded in memory of Bernardo “Bardo” Eggesbø.

Leiomyosarcoma Research UK has joined Cancer52.

The Rare Cancers Act 2026 will prioritise long overlooked aspects of research, and has the potential to transform outcomes for those affected by rare and less common cancers.

MOVE Against Cancer has joined Cancer52! Their mission is to support and empower everyone impacted by cancer to be more active because movement matters. They deliver evidence-based support through 5k Your Way community groups, tailored online programmes and accessible resources, improving wellbeing and supporting health outcomes during and after treatment.

In a breakthrough moment, the Government has made a clear commitment to focus specifically on rare and less common cancers within a national cancer strategy. A full chapter of the plan is dedicated to these cancers, which is an important step forward that recognises their unique challenges. Their prominence in the National Cancer Plan for England is a credit to the tireless efforts of our cancer charity members and the wider rare and less common cancer community.

Cancer52 have collated a collection of case studies from charity members, titled Tackling health inequalities in rare and less common cancers.